Apyx Medical (APYX) Set to Announce Quarterly Earnings on Friday

Apyx Medical (NASDAQ:APYX) will post its quarterly earnings results before the market opens on Friday, November 8th. Analysts expect Apyx Medical to post earnings of ($0.15) per share for the quarter. Apyx Medical has set its FY 2024 guidance at EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Apyx Medical (NASDAQ:APYX) last issued its earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. The business had revenue of $12.15 million for the quarter, compared to the consensus estimate of $12.67 million. During the same period in the previous year, the firm earned ($0.11) EPS. On average, analysts expect Apyx Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Apyx Medical Trading Up 0.9 %

Shares of APYX stock opened at $1.17 on Wednesday. The company’s fifty day simple moving average is $1.21 and its two-hundred day simple moving average is $1.33. The company has a debt-to-equity ratio of 2.26, a current ratio of 5.33 and a quick ratio of 4.45. Apyx Medical has a 1 year low of $0.97 and a 1 year high of $3.26. The stock has a market capitalization of $40.53 million, a price-to-earnings ratio of -1.43 and a beta of 1.21.

Analyst Ratings Changes

Several research firms have recently weighed in on APYX. BTIG Research began coverage on shares of Apyx Medical in a report on Thursday, October 17th. They issued a “neutral” rating on the stock. Craig Hallum raised shares of Apyx Medical to a “strong-buy” rating in a report on Thursday, October 24th. Finally, JMP Securities reaffirmed a “market perform” rating on shares of Apyx Medical in a report on Monday, September 16th.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.